Sebastian Michels

Ulm, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Multimodal analysis of cell-free DNA identifies epigenetic biomarkers for amyotrophic lateral sclerosis diagnosis and progression.

Multimodal analysis of cell-free DNA identifies epigenetic biomarkers for amyotrophic lateral sclerosis diagnosis and progression.

Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026

Feasibility and Tolerability of Ketogenic Interventions in Amyotrophic Lateral Sclerosis-A Dose-Finding Case Series.

Feasibility and Tolerability of Ketogenic Interventions in Amyotrophic Lateral Sclerosis-A Dose-Finding Case Series.

Journal: Nutrients
Published: March 25, 2026

Multimodal analysis of cell-free DNA identifies epigenetic biomarkers for amyotrophic lateral sclerosis diagnosis and progression.

Multimodal analysis of cell-free DNA identifies epigenetic biomarkers for amyotrophic lateral sclerosis diagnosis and progression.

Journal: The Journal of clinical investigation
Published: January 22, 2025

Alterations of Fat and Ketone Body Metabolism in ALS and SMA-A Prospective Observational Study.

Alterations of Fat and Ketone Body Metabolism in ALS and SMA-A Prospective Observational Study.

Journal: European journal of neurology
Published: December 29, 2024

TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in amyotrophic lateral sclerosis and frontotemporal dementia.

TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in amyotrophic lateral sclerosis and frontotemporal dementia.

Journal: The Journal of clinical investigation
Published: April 16, 2024

Multi-omic quantitative trait loci link tandem repeat size variation to gene regulation in human brain.

Multi-omic quantitative trait loci link tandem repeat size variation to gene regulation in human brain.

Journal: Nature genetics
Published: February 26, 2024

TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in ALS/FTD and related disorders.

TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in ALS/FTD and related disorders.

Journal: bioRxiv : the preprint server for biology
Published: February 08, 2024

Association of blood lipids with onset and prognosis of amyotrophic lateral sclerosis: results from the ALS Swabia registry.

Association of blood lipids with onset and prognosis of amyotrophic lateral sclerosis: results from the ALS Swabia registry.

Journal: Journal of neurology
Published: November 28, 2022

Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage.

Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage.

Journal: Brain : a journal of neurology
Published: June 18, 2022

Predictive parameters of early respiratory decline in amyotrophic lateral sclerosis.

Predictive parameters of early respiratory decline in amyotrophic lateral sclerosis.

Journal: European journal of neurology
Published: March 29, 2022

Alternative polyadenylation transcriptome-wide association study identifies APA-linked susceptibility genes in brain disorders.

Alternative polyadenylation transcriptome-wide association study identifies APA-linked susceptibility genes in brain disorders.

Journal: Nature communications
Published: February 28, 2022

Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis.

Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis.

Journal: JAMA neurology
Published: January 10, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026